Key Takeaways
- In a 36-patient cohort undergoing transmastoid-epitympanum facial nerve decompression for Bell's palsy, an intraoperative direct stimulation threshold of ≤1.5 mA was associated with a 85.0% good recovery rate versus 43.8% in patients with thresholds >1.5 mA or no response at 3 mA (P = 0.009).
- Only 55.6% (20/36) of patients produced a recordable facial nerve response, and all responders fell within a 0.1–1.5 mA range; 44.4% (16/36) had no waveform even at 3 mA.
- Age, sex, side of palsy, surgical timing (1–2 vs. 2–3 months), and preoperative electroneurography (ENoG) did not differ significantly between recovery groups (all P > 0.05).
- In a partially excitable facial nerve, IONM alone is unreliable for nerve localization — surgeons must rely on constant anatomic landmarks to avoid iatrogenic injury.
Clinical Context
Bell's palsy (idiopathic facial palsy) carries an incidence of roughly 11.5–53.3 per 100,000, peaking between ages 15 and 45. Most patients recover with conservative management, but a subset with severe degeneration — conventionally defined by ENoG decline exceeding 90% — fails medical therapy and becomes a candidate for surgical decompression. A 2019 meta-analysis supported decompression within 3 months of onset, with comparable outcomes for transmastoid and middle cranial fossa approaches.
Intraoperative Facial Nerve (FN) monitoring is now routine in otologic–lateral skull base and head-and-neck oncology procedures, where it localizes the nerve and provides real-time warning during dissection. Its role in decompression for an already-injured nerve, however, is less defined: the diseased nerve is hypoexcitable, and the reliability of direct stimulation thresholds — both for localization and for prognostication — has remained an open question. This study from a high-volume tertiary surgical center (Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tiantan Hospital) examined whether the intraoperative FN direct stimulation threshold predicts postoperative FN functional recovery.
Clinical Evidence & Cohort Breakdown
This retrospective cohort included 36 patients with Bell's palsy (male-to-female ratio 1.57:1; mean age 45.64 ± 15.06 years, range 18–68) treated between October 2015 and October 2022. Inclusion required: failed conservative therapy ≥1 month with House-Brackmann (HB) grade V–VI; preoperative ENoG decline >90% versus the healthy side; surgery within 3 months of onset; and intraoperative FN monitoring with a documented direct stimulation threshold. Mean follow-up was 16.3 ± 4.0 months (range 12–24). Good recovery was defined as postoperative HB grade I–II; poor recovery as grade III or worse.
Baseline characteristics by recovery status:
| Parameter | Good Recovery (n = 24) | Poor Recovery (n = 12) | P value |
|---|---|---|---|
| Age (years, mean ± SD) | 44.17 ± 15.32 | 48.58 ± 14.73 | 0.415 |
| Male sex, n (%) | 16 (66.7%) | 6 (50.0%) | 0.471 |
| Left-sided palsy, n (%) | 13 (54.2%) | 7 (58.3%) | 1.000 |
| ENoG — Oculi (%, mean ± SD) | 93.3% ± 3.1% | 93.6% ± 2.9% | 0.410 |
| ENoG — Oris (%, mean ± SD) | 94.0% ± 2.9% | 92.8% ± 3.2% | 0.130 |
| Follow-up (months, mean ± SD) | 16.17 ± 4.10 | 16.58 ± 3.99 | 0.390 |
| Surgery at 1–2 months, n (%) | 12 (50.0%) | 7 (58.3%) | 0.637 |
Recovery stratified by intraoperative stimulation threshold:
| Group | Definition | Good Recovery (n = 24) | Poor Recovery (n = 12) | P value |
|---|---|---|---|---|
| A (n = 20) | Threshold ≤1.5 mA | 17 (85.0%) | 3 (15.0%) | 0.009 |
| B (n = 16) | Threshold >1.5 mA or no response at 3 mA | 7 (43.8%) | 9 (56.2%) | — |
Overall, 24 patients (66.7%) achieved good recovery and 12 (33.3%) had poor recovery. No patient developed cerebrospinal fluid leak, tympanic membrane perforation, or middle ear infection. Post-hoc power calculation for the good-recovery endpoint (85% vs. 44%, α = 0.05) yielded 0.77.
Intraoperative IONM Protocol & Technical Pearls
All monitoring was performed by a single operator using a Nicolet system, and all surgery by a single experienced surgeon via a transmastoid-epitympanum approach.
- Electrode placement. Insert subdermal needle electrodes into the ipsilateral eyebrow tail (orbicularis oculi) and the oral commissure (upper and lower orbicularis oris). Place the ground electrode subcutaneously at the presternal region. Connect electrodes through the junction box to the preamplifier; a facial muscle EMG response exceeding 100 μV is displayed on the monitor.
- Surgical exposure and landmark-based localization. Perform a retroauricular "C" incision, expose the mastoid cortex, and complete mastoidectomy from the middle cranial fossa down to the mastoid tip/digastric ridge, anteriorly to the posterior external auditory canal wall, and posteriorly to the sigmoid sinus. Localize the nerve by constant landmarks: the anterior margin of the digastric ridge marks the lower vertical segment (stylomastoid foramen); the angle between the horizontal and posterior semicircular canals marks the upper vertical segment; the region between the canals corresponds to the vertical segment. Expose the chorda tympani, open the facial recess, expose the incudostapedial joint, then open the epitympanum anteriorly to expose the malleus-incus joint. Disarticulate the incudostapedial joint first, then the malleus-incus joint; remove the incus, remove the malleus head, drill the posterior buttress and cog, and expose the horizontal segment and geniculate ganglion. Skeletonize the FN ≥180° from geniculate ganglion to vertical segment.
- Threshold testing. Directly stimulate the geniculate ganglion segment with the stimulating probe, beginning at 0.1 mA and increasing stepwise until a facial muscle response is obtained; record the threshold. Do not exceed 3 mA — if no response is elicited at 1.5 mA, escalating to 3 mA adds no useful information.
- Decompression and reconstruction. After threshold recording, incise the epineurium and decompress the nerve from the geniculate ganglion to the stylomastoid foramen. Reconstruct hearing with a titanium ossicular prosthesis, close in layers, and apply a compressive dressing.
- Interpretation pearl. In a hypoexcitable nerve, absence of a stimulation response does not equate to nerve transection. Do not use IONM as the sole means of localizing the FN in Bell's palsy decompression — false-negative stimulation can misdirect the surgeon and risk iatrogenic injury. Anatomic landmarks remain the primary localization tool, particularly for surgeons early in their decompression experience.
Clinical Implications for Surgeons & IONM Specialists
- Threshold as a prognostic biomarker. A recordable FN response at ≤1.5 mA predicts a favorable postoperative course (85.0% good recovery), while an absent response at 3 mA signals a roughly 56% risk of poor recovery. This information can inform postoperative counseling and rehabilitation planning.
- Cap the stimulation ceiling. Because all responders in this cohort fell within 0.1–1.5 mA, escalating beyond 1.5 mA to 3 mA yields no additional localizing value and should be avoided.
- Do not over-trust IONM for localization. Nearly half of patients had no recordable response at 3 mA; anatomic landmark identification is mandatory to prevent iatrogenic FN injury.
- ENoG as a surgical trigger, not a discriminator. All included patients had ENoG decline >90%, which explains the absence of between-group ENoG differences; the authors advocate surgery once degeneration exceeds 90%. Future work should sub-stratify ENoG to define its prognostic role.
- Caveats. Single-center design, small sample size (n = 36), and retrospective collection limit generalizability; multicenter validation is warranted. Patients with thresholds ≤1.5 mA but poor outcomes deserve focused prospective analysis.
Reference
Wang P, Zhang W, Wang Y, Xia Y. Predictive Value of Intraoperative Facial Nerve Response Thresholds on the Recovery Effect After Facial Nerve Decompression. Medical Journal of Peking Union Medical College Hospital. 2023;14(6):1246–1250. doi:10.12290/xhyxzz.2023-0161.
Medical Disclaimer: This article is provided for informational and educational purposes only and does not constitute medical advice. Clinical decisions regarding Intraoperative Neurophysiological Monitoring (IONM) and surgical management should be made by qualified healthcare professionals based on individual patient assessment and institutional protocols.